Cargando…
Antiviral therapy and immunotherapy of COVID-19
The pharmacological treatment of COVID-19 has evolved in the months since the description of the disease. Published observational studies and, above all, clinical trials have highlighted drugs that are useful as well as ruled out any benefit from other drugs used at the beginning of the pandemic. Th...
Autores principales: | Crespillo, Clara, Moreno, Santiago |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683015/ https://www.ncbi.nlm.nih.gov/pubmed/34598429 http://dx.doi.org/10.37201/req/s01.17.2021 |
Ejemplares similares
-
Thrombose und COVID-19
por: Tzaneva, Stanislava
Publicado: (2021) -
Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications
por: Torres, Antoni, et al.
Publicado: (2022) -
Approach to COVID-19 pandemic management in Madrid. Chronic of a year
por: Candel, Francisco Javier, et al.
Publicado: (2021) -
Respiratory co-and superinfections in COVID-19
por: del Pozo, José L
Publicado: (2021) -
COVID-19: Impact on prescribing and antimicrobial resistance
por: Ruiz-Garbajosa, Patricia, et al.
Publicado: (2021)